Schedule 13G ownership disclosure
BELLICUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 079481107
Event date: 2018-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-027124
- Form type
- SC 13G
- Filer
- BAKER BROS. ADVISORS LP
- CIK
- CIK 1263508
- Filed
- May 10, 2018
- Reporting period
- Apr 30, 2018
- Description
- Schedule 13G beneficial ownership